CardioFocus, based in Marlborough, MA, obtained FDA regulatory approval for its HeartLight Excalibur Balloon as a treatment option for paroxysmal atrial fibrillation. The system ablates cardiac tissue and relies on the same balloon design as the previously approved HeartLight Ablation System. The latest design improves the speed of ablation and how much tissue is targeted.
The company’s HeartLight technology is used during pulmonary vein isolation procedures, using the balloon to isolate the target area and providing the physician with a direct view of the tissue being worked on. A laser is used to ablate cardiac tissue without having to rely on X-rays or EP cardiac mapping to find and kill the target.
Medgadget flashbacks: CardioFocus HeartLight Ablation System with Direct Visual Guidance FDA Approved…; New CardioFocus HeartLight Excalibur Balloon Cleared in Europe…
Product page: HeartLight Excalibur Balloon…
You may be interested
JAMA study shows how surgeons successfully reduced prescribed opioidsFrank - Mar 25, 2019
It may not be rocket science, but a group of surgeons at the University of Michigan’s Michigan Medicine have devised…
Tom Petty: Read our 1994 interview with the late musician promoting the release of WallflowersFrank - Mar 25, 2019
Frank's source: http://www.independent.co.uk/arts-entertainment/music/features/tom-petty-interview-wildflowers-sunday-review-the-heartbreakers-elvis-presley-a7980996.html
Eminem’s new album is finished, according to longtime collaboratorFrank - Mar 25, 2019
Frank's source: http://www.independent.co.uk/arts-entertainment/music/news/eminem-new-album-finished-release-date-denaun-porter-marshall-mathers-a7981981.html